Histone deacetylases and cancer: causes and therapies
Paul A. Marks(Memorial Sloan Kettering Cancer Center), Richard A. Rifkind(Memorial Sloan Kettering Cancer Center), Victoria M. Richon(Memorial Sloan Kettering Cancer Center), Ronald Breslow(Columbia University), Thomas A. Miller(Columbia University), William Kevin Kelly(Memorial Sloan Kettering Cancer Center)
Cited by 1,856
Abstract
Related Papers
Hemoglobin Synthesis in Murine Virus-Induced Leukemic Cells <i>In Vitro:</i> Stimulation of Erythroid Differentiation by Dimethyl Sulfoxide
Charlotte Friend, William Scher, J. G. Holland et al.|Proceedings of the National Academy of Sciences|1971|1.4k
The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases
Joseph W. Landry, Ann Sutton, Stefan T. Tafrov et al.|Proceedings of the National Academy of Sciences|2000|966
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Victoria M. Richon, Stéphane Emiliani, Eric Verdin et al.|Proceedings of the National Academy of Sciences|1998|913